FDA panel backs infant doses for kids' Tylenol

(AP) -- Federal health experts say dosing instructions for children younger than 2 years old should be added to Children's Tylenol and similar products containing acetaminophen, the popular pain reliever and fever reducer.

A panel of advisers voted 21-0 in favor of adding doses for babies and toddlers to over-the-counter acetaminophen formulas. The FDA has convened a two-day meeting to consider changes that will make the formulas safer and easier to use. The products under discussion include Johnson & Johnson's Children and Infants' Tylenol, Novartis' Triaminic and other brands.

These products have never contained dosing information for children under 2 to encourage parents to seek medical attention for sick infants.

But the FDA's panel said the lack of information contributes to confusion and can cause accidental overdose.

©2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Citation: FDA panel backs infant doses for kids' Tylenol (2011, May 18) retrieved 29 March 2024 from https://medicalxpress.com/news/2011-05-fda-panel-infant-doses-kids.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

FDA weighs new dose info for kids' pain relievers (Update)

 shares

Feedback to editors